Table 2 Questions raised by volunteers at screening appointments
From: Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya
Question category | Number of questions asked | Percentage (%) |
|---|---|---|
n = 167 | ||
Effects of malaria infection and treatment: short and long-term | 27 | 16% |
Details of in-patient stay and travel out of Nairobi | 20 | 12% |
Availability of test results | 19 | 11% |
Blood sampling | 13 | 8% |
Further explanation of study logistics | 13 | 8% |
Parasite strain used in CHMI | 13 | 8% |
Prior studies of PfSPZ Challenge | 10 | 6% |
Rationale for allocation to groups | 9 | 5% |
Malaria treatment | 7 | 4% |
Study start date | 7 | 4% |
Compensation | 6 | 4% |
Post CHMI follow-up | 5 | 3% |
Purpose of the research | 4 | 2% |
Possibility of failure of infection | 3 | 2% |
Criteria for malaria treatment | 3 | 2% |
Failure to cure malaria infection | 2 | 1% |
Injection sites of PfSPZ Challenge | 2 | 1% |
Proof of participation in the study | 2 | 1% |
Resistance of PfSPZ Challenge to anti-Malarial drugs | 2 | 1% |